publication date: Dec. 21, 2010

In this issue: 

NCI To Recompete Drug Discovery Groups In 2003 As Program Nears Its 20th Year;

Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program;

Survivorship Research RFA To Be Reissued; Biomedical Imaging Institute Names 10 to Advisory Council

(8-page issue).

Download (PDF 469KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.